JMP Securities Downgrades Trevena(TRVN.US) to Hold Rating
Compass Therapeutics Names Barry Shin CFO
Trevena (TRVN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Trevena Appoints Katrine Sutton as New CFO
Trevena Cut to Neutral From Buy by HC Wainwright & Co.
Trevena Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Trevena Analyst Ratings
H.C. Wainwright Downgrades Trevena(TRVN.US) to Hold Rating, Cuts Target Price to $5
Analysis of Trevena's Hold Rating: Balancing High Potential Assets With Financial Instability
Trevena Q3 2024 GAAP EPS $(5.79) Beats $(7.38) Estimate, Sales $283.00 Down From $180.00K YoY
Trevena Faces Leadership Changes Amidst Financial Challenges
Trevena | 10-Q: Q3 2024 Earnings Report
Earnings Flash (TRVN) TREVENA Reports Q3 Revenue $283,000
Trevena 3Q Loss $4.94M >TRVN
Express News | Trevena Reports Third Quarter 2024 Results and Provides Business Update
Trevena Executives Terminated but Remain as Advisors
Sector Update: Health Care Stocks Retreat Late Afternoon
Sector Update: Health Care
Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge
Why Trevena (TRVN) Stock Is Down 43% Today